Apotex's Generic Losartan Potassium Receives Approval in US
Enforcement Report - Week of May 22, 2024
Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
Granules India Received ANDA Approval for Losartan and HCL Tablets
MSN's Generic Losartan Potassium Receives Approval in the U.S.
Enforcement Report - Week of July 12, 2023
Granules India Limited Received ANDA Approval for Losartan Potassium Tablets
Drug firm Granules India on Monday said it has received approval from the US health regulator to market a generic product to treat high blood pressure. The company has received approval from the US Food & Drug Administration (USFDA) to market Losartan Potassium tablets in strengths of 25 mg, 50 mg, and 100 mg, Granules India said in a regulatory filing.
Enforcement Report - Week of July 6, 2022